ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DVA DaVita Inc

126.11
-1.53 (-1.20%)
Apr 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 749,549
Bid Price
Ask Price
News -
Day High 128.57

Low
71.51

52 Week Range

High
141.54

Day Low 125.64
Company Name Stock Ticker Symbol Market Type
DaVita Inc DVA NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.53 -1.20% 126.11 20:00:00
Open Price Low Price High Price Close Price Prev Close
127.60 125.64 128.57 126.11 127.64
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
15,707 749,549 $ 126.50 $ 94,818,143 - 71.51 - 141.54
Last Trade Time Type Quantity Stock Price Currency
19:00:00 113,361 $ 126.11 USD

DaVita (DVA) Options Flow Summary

Overall Flow

Bullish

Net Premium

720k

Calls / Puts

216.67%

Buys / Sells

50.00%

OTM / ITM

111.11%

Sweeps Ratio

0.00%

DaVita Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
11.06B 87.70M - 12.14B 691.54M 7.89 15.99
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

DaVita News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No DVA Message Board. Create One! See More Posts on DVA Message Board See More Message Board Posts

Historical DVA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week132.61133.077125.64129.68441,468-6.50-4.90%
1 Month138.93139.3539125.64133.77492,180-12.82-9.23%
3 Months104.70141.54104.70126.02841,55721.4120.45%
6 Months76.26141.5475.14106.88983,10349.8565.37%
1 Year84.01141.5471.51101.27893,56342.1050.11%
3 Years113.48141.5465.2899.50793,12712.6311.13%
5 Years51.08141.5443.4084.671,066,61975.03146.89%

DaVita Description

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government ( primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Your Recent History

Delayed Upgrade Clock